Status:
RECRUITING
A Long-term Follow-up Study in Participants Who Received CS-101
Lead Sponsor:
Children's Hospital of Fudan University
Conditions:
Beta-Thalassemia
Eligibility:
All Genders
3-17 years
Phase:
NA
Brief Summary
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)
Detailed Description
This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189) . Subjects in the CS-101-03 study will be entered into lo...
Eligibility Criteria
Inclusion Criteria:
- Participants (or his or her legally appointed and authorized representative or guardian) must sign and date informed consent form (ICF) and, where applicable, an assent form
- Participants must have received CS-101 infusion in last IIT study
Exclusion Criteria:
- There are no exclusion criteria
Key Trial Info
Start Date :
June 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT06479616
Start Date
June 18 2024
End Date
June 1 2027
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 201102